Wegovy 7.2mg: Everything you need to know about the higher dose

With the news of Wegovy's new 7.2mg dose, the gap between Wegovy and Mounjaro has never been closer. And with Mounjaro prices rising in the UK, many patients are asking the same question: is it worth switching?

New research shows that a higher 7.2mg dose of Wegovy can encourage weight loss outcomes similar to Mounjaro [1]. For patients who have plateaued or are rethinking their options in light of rising treatment costs, the higher dose could be a game-changer.

At Juniper, we specialise in helping patients make this decision safely, efficiently, and cost-effectively with a 7-day switching protocol that means you don't lose progress.

How does Wegovy 7.2mg compare with Mounjaro?

Clinical trials now show Wegovy 7.2mg achieving outcomes almost identical to Mounjaro:

• Wegovy 2.4mg: 17.5% average weight loss
• Wegovy 7.2mg: 20.7% average weight loss
• Mounjaro 15mg: 20.9% average weight loss

In fact, 33% of patients achieved more than 25% weight loss with a 7.2mg dose of Wegovy [1]. Side effects remained consistent with lower doses of semaglutide, meaning most patients who tolerate Wegovy at 2.4mg should tolerate the higher dose too.

Bottom line: Wegovy 7.2mg now offers results that are within reach of Mounjaro, but at a potentially lower cost.

Who is Wegovy 7.2mg for?

This dose isn't about pushing everyone higher. It's about providing an option for those who need it.

You may benefit from the higher dose if you:

• Are already on Wegovy 2.4mg, but have plateaued or need stronger appetite suppression
• Have tolerated Wegovy well so far, with minimal or manageable side effects
• Are reconsidering Mounjaro due to side effects or rising costs
• Want to continue your progress without starting over

If you're switching from Mounjaro, your clinician can match you to an equivalent Wegovy dose, including the new 7.2mg, so your progress continues uninterrupted.

It's important to remember, though, that 7.2mg is not a starting dose. If you're new to Wegovy, you will still need to titrate through the dosing schedule before being considered.

Can you switch from Mounjaro to Wegovy without starting again?

If you're thinking about switching from Mounjaro to Wegovy, the good news is that it's both safe and straightforward.

When making the switch, Juniper patients don’t need to restart at the lowest dose. If clinically appropriate, they can continue at a higher dose aligned with recent treatment history. Plus, our switching protocol has only a 7-day gap between medications, compared to 28 days with most other providers.

Juniper’s clinical switching protocol is designed to make the change simple and safe:

• Review — Your clinician assesses your treatment history and dose tolerance.
• Match — If eligible, you start on an equivalent high dose to avoid losing progress.
• Transition — Only a 7-day window is required between your last Mounjaro dose and your first Wegovy dose (most providers require 28 days).
• Support — Pharmacist check-ins, dose adjustments, and lifestyle guidance keep you on track.

Start your Wegovy switch today →

Is Wegovy 7.2mg available in the UK yet?

Novo Nordisk has submitted the 7.2mg dose for approval with the European Medicines Agency (EMA) [3]. Once approved, rollout across the UK is expected soon. If you're already progressing through Wegovy's dosing schedule, 7.2mg could become available by the time you'd naturally reach the higher dose.

How much does Wegovy cost?

How do side effects at 7.2mg compare?

The STEP UP trial showed that the side effects of Wegovy at 7.2mg were consistent with those seen at lower doses:

• Most common: nausea, diarrhoea, constipation, bloating
• Less common but noted: tingling or skin sensitivity (dysaesthesia), typically mild and short-lived

Encouragingly, 85% of patients experiencing side effects recovered while continuing treatment, with only 5.4% of people on 7.2mg stopping due to side effects (compared to 4% on 2.4mg) [5].

This means that if you've tolerated Wegovy well so far, you're likely to manage the higher dose as well. However, everyone responds to medication differently. Some people may experience new side effects when switching, while others find that previous side effects disappear.

At Juniper, we take a cautious, personalised approach to dosing and offer ongoing clinical support to help you manage any side effects and stay on track with your progress.

Why choose Juniper?

We see Wegovy 7.2mg as an exciting new tool to help manage weight, but your journey is unique, so your treatment plan should be too.

With the Juniper Programme, you can access weight loss medication tailored to your health and goals — never one-size-fits-all. Our app helps you track progress, connect with your care team, adjust medication as needed, and access expert support. You'll also get structured tools to build lasting habits and ongoing care.

Continue your weight loss journey with Wegovy, a groundbreaking weight loss injection that mimics the GLP-1 hormone to help control cravings, delay stomach emptying, and keep you feeling fuller for longer.

Plus, in response to the Mounjaro price increase, we’ve lowered the price of our Wegovy programme by 25%, and we’re making it easier for patients to switch without starting over, so that effective treatment remains within reach for as many people as possible.

We help you make lifestyle and habit changes, and we’re in it with you for the long run, having helped thousands of women achieve their weight loss goals.

Frequently asked questions

If you’re considering a move from Mounjaro to Wegovy, you may have some practical questions about how the process works, what to expect, and how Juniper can support you.

How does 7.2mg compare to the current 2.4mg dose?

The STEP UP trial followed over 1,400 randomised adults with obesity [1]. Results showed:

• Patients on 2.4mg of Wegovy lost an average of 17.4% body weight
• Patients on 7.2mg of Wegovy lost an average of 20.7% body weight
• Patients on placebo lost an average of just 2.4% body weight

For context, during clinical trials, Mounjaro patients lost 20.9% of their body weight after 72 weeks, which means the new Wegovy dose provides similar results while maintaining the familiar safety profile of semaglutide [6].

Is 7.2mg the "best" Wegovy dose?

There's no single "best" dose, only the dose that works best for you. For some, lower doses are enough. For others, 7.2mg may unlock further progress. The key is working with a clinician who understands your health history, your goals, and your tolerability, so they can guide you towards the treatment plan that works best for you.

Why is Juniper's switch faster than other providers?

Most providers require a 28-day break between Mounjaro and Wegovy. Juniper uses a clinically safe 7-day transition protocol, meaning you spend less time off treatment and don't lose momentum.

Is Wegovy more affordable than Mounjaro long-term?

With the recent Mounjaro price increases in the UK, and Juniper lowering Wegovy programme prices, many patients now find Wegovy the more sustainable long-term choice.

Can you access Wegovy 7.2mg through the NHS?

Currently, the NHS prescribes Wegovy up to 2.4mg under strict criteria. Because Juniper is a private provider, our patients will gain access faster, so those who are eligible will be among the first to receive the higher dose.

What happens if you switch and 7.2mg isn't available yet?

If you switch to Wegovy, you will continue on the current licensed Wegovy doses (up to 2.4mg). Once 7.2mg becomes available in the UK, Juniper patients who are eligible will be among the first to step up under clinical guidance.

Will my side effects be different on Wegovy compared to Mounjaro?

Most people find the side effects similar, since both medications act on GLP-1 pathways. If you tolerated Mounjaro well, you’ll likely tolerate Wegovy too. Any changes are usually temporary and manageable with clinician support.

How quickly will I see results after switching?

Because you don’t restart from the lowest dose with Juniper, you’ll continue at an equivalent dose. That means your appetite control and weight loss should continue without interruption.

‍

Image credit: Pexels